Okay, so hospital readmissions are bad and we should prevent them. A good first step is understanding what diagnoses are most often related to readmissions. An Agency for Healthcare Research & Quality Statistical Brief gives us 2011 data, broken down by payer type. (Stat. Brief) In 2011 there were 3.3 million all-cause readmissions within thirty days after a hospital discharge. These readmissions cost $41.3 billion but it is important to remember that not all these readmissions are inappropriate or avoidable. Some are actually planned, for example, for follow-up procedures. And the all-cause readmission measure means many of the subsequent readmissions were for problems unrelated to the original admission. For Medicare, the largest admission diagnoses followed by a readmission were congestive heart failure, 135,000 readmissions; septicemia, 92,000 readmissions; and pneumonia, 88,000 readmissions. These readmissions represented $4.3 billion in hospital costs and over 17% of all Medicare readmissions. For Medicaid, adult readmissions followed mood disorders, 41,600, most commonly, followed by schizophrenia, 35,800, and diabetes 23,700 readmissions. These represented 15% of all Medicaid readmissions. For privately insured people the highest admission followed by readmission was maintenance chemotherapy at 25,500, almost none of which are likely avoidable; mood disorders, 19,600, and complications of surgical or medical care, 18,000 readmissions, most of which we suspect were avoidable. These three diagnoses accounted for only about 10% of all commercial readmissions. The high number of mental illness related readmissions in Medicaid and private insurance are likely signs of poor outpatient care, especially a failure to ensure that a medication regiment is appropriate and adhered to. For uninsured patients, the diagnoses are similar to those in Medicaid, with mood disorders first at 12,200; alcoholism at 8,800 and diabetes at 7,400, with these being about 18% of all uninsured patient readmissions. This data, which hospitals and payers should already have access to, should help target readmission prevention efforts.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
September 24, 2023
Relative Spending and Utilization for Medicare Advantage Plans
Medicare Advantage plans have lower utilization and spending than does the Medicare fee-for-service program.
Commentary
September 23, 2023
Stop-loss Insurance Claims for Self-funded Employers
A report on stop-loss insurance reveals increases in number of claims and average cost of…
Commentary
September 22, 2023
Coronamonomania Lives Forever, Part 224
From far across the Pacific comes yet another set of summaries, just like the virus.